The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on Wednesday seeking to raise capital ...

Researchers suggest early interventions, such as probiotics, could help nurture a healthy gut microbiome and potentially reduce the risk of neurodevelopmental challenges.

Cryo-EM reveals the first detailed structure of the Bornavirus nucleoprotein–RNA complex, uncovering unique RNA binding and assembly mechanisms.

A new single‑cell method, CIPHER‑seq, measures RNA and proteins together to reveal real‑time cytokine signaling.

Scientists mapped the maternal–fetal interface revealing new cell types, genetic links, and mechanisms behind pregnancy complications.

PRECISE-SG100K is designed to integrate genomic, proteomic, lifestyle, imaging, and other health data from 10,000 Singaporean residents.

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Transfer learning can help biopharmaceutical developers to leverage historical data to guide the development of new manufacturing processes.

Using rapid protein degradation, chemogenomics, and super‑resolution microscopy in mouse embryonic stem cells, the team dissected the distinct contributions of BRD2 and BRD4 to transcription.

HHMI researchers have developed an in vivo proteomic method for identifying proteins in the BBB that may regulate access through vessels.

Desert microbes yield enzymes with potential to improve pharmaceutical bioprocessing efficiency and resilience.

L1, termed IB101, which was found to form a defined binding pocket that precisely positions the active moiety in a reactive conformation.